News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Apr / 2026

April 2026
M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

« Mar

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Gevorg Tamamyan։ We Are Looking for Champions Around the World

Gevorg Tamamyan։ We Are Looking for Champions Around the World

Phase 3 BATTMAN Trial Launches BOT/BAL in MSS or pMMR Metastatic Colorectal Cancer

Phase 3 BATTMAN Trial Launches BOT/BAL in MSS or pMMR Metastatic Colorectal Cancer

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

immunosarc II Trial: Sunitinib + Nivolumab in Advanced Clear Cell Sarcoma

immunosarc II Trial: Sunitinib + Nivolumab in Advanced Clear Cell Sarcoma

Waleed Arafat: Final Days to Submit Abstracts for ISCO 2026

Waleed Arafat: Final Days to Submit Abstracts for ISCO 2026

Pavankumar Anné: Excited to be joining OncoDaily for the upcoming ZS AI in Oncology session during ASCO

Pavankumar Anné: Excited to be joining OncoDaily for the upcoming ZS AI in Oncology session during ASCO

2 New ES-SCLC Treatments Backed by EMA: A Major Shift in Care

2 New ES-SCLC Treatments Backed by EMA: A Major Shift in Care

Dr. Richard Goldberg on Why FDA Must Keep Pace as CRC Rises in Younger Adults

Dr. Richard Goldberg on Why FDA Must Keep Pace as CRC Rises in Younger Adults

Giuseppe Giannini

Nov 13, 2025 9:53 am

Voices

Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial

Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial

Oct 2, 2025 10:42 am

Voices

Giuseppe Curigliano: The ROME Trial – A National Effort to Bring Genomics to the Heart of Cancer Care in Italy

Giuseppe Curigliano: The ROME Trial – A National Effort to Bring Genomics to the Heart of Cancer Care in Italy

Sep 30, 2025 12:02 pm

Voices

Aakash Desai: Big Step Forward for Precision Oncology with Randomized Evidence

Aakash Desai: Big Step Forward for Precision Oncology with Randomized Evidence

Sep 4, 2025 3:26 am

Science

Svetlana Nikic: Can Concordance Between Liquid and Tissue Biopsies Change Outcomes?

Svetlana Nikic: Can Concordance Between Liquid and Tissue Biopsies Change Outcomes?

Headlines

NCCN 2026 Annual Conference Prepares Cancer Care Providers Worldwide for Healing the Whole Patient

HER2 Heterogeneity in Breast Cancer May Explain Why Some Tumors Escape T-DXd

PRINCE Trial: Lu-PSMA-617 Plus Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Abstract Submission is Open for SIOG 2026 in Valencia - International Society of Geriatric Oncology

Catharine Young: This is Why We Fund Science

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Breast Cancer Global fight against cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO immunotherapy NSCLC MD Anderson Cancer Center cancer treatment cancer awareness Research colorectal cancer ASCO24 Childhood Cancer clinical trials AACR prostate cancer FDA UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Robert Orlowski Myeloma NCI Pancreatic Cancer Myeloma Paper of the Day National Cancer Institute Vivek Subbiah American Society of Clinical Oncology Paolo Tarantino AI radiation oncology healthcare cervical cancer IASLC WHO Memorial Sloan Kettering Cancer Center ASCO25 multiple myeloma Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}